Healthcare News
GLP-1 and health: Beyond weight loss in the Ozempic era
This week, the White House announced a deal with Eli Lilly and Novo Nordisk to lower the cost of their GLP-1 weight loss drugs, Wegovy and Zepbound. The move could significantly expand access to these treatments for people with diabetes and obesity.
When Is Hiatal Hernia Life-Threatening?
For most people, a small hiatal hernia, also known as a stomach hernia, will not cause symptoms. With larger hernias, however, symptoms may include heartburn, belching, a weird taste in your mouth, or regurgitation. Typically, these are not serious, but in some cases, they can cause potentially life-threatening complications.
How to Check for a Hiatal Hernia
A hiatal hernia occurs when a portion of the stomach, and sometimes other abdominal structures, is able to bulge upward into the chest through a defect in the diaphragm. Since most hiatal hernias do not cause symptoms, they are usually discovered during a routine chest X-ray for an unrelated condition. At other times, a hiatal hernia may be suspected in people with severe acid reflux who fail to respond to antacids or other treatments. For such cases, there are several tests healthcare providers can use to confirm the diagnosis.
Once-weekly eloralintide leads to 20% weight loss in Phase II trial
A multicenter team including Endeavor Health and Eli Lilly found that once-weekly eloralintide produced dose-dependent weight loss up to 20% over 48 weeks in adults with obesity or overweight without type 2 diabetes.
Cholecystectomy Delay Linked to Substantially Increased Complication Risk
Patients with gallstone disease blocking the bile duct (choledochlithiasis) who do not have gall bladder removal in the same hospital admission as endoscopic retrograde pancreatography (ERCP) have as much as a 17-fold increase in the risk for biliary complications.
Popular weight-loss drugs show added heart protection for diabetes patients
Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes. Researchers at the Technical University of Munich (TUM) and Harvard Medical School have demonstrated this result using insurance claims data.
BL-760 dye shows potential to decrease risk in laparoscopic cholecystectomy procedure
Researchers at Children’s National Hospital recently conducted a study testing BL-760, a “near-infrared” fluorescent dye that makes bile ducts more visible during laparoscopic cholecystectomy, or the removal of the gallbladder.
Hiatal Hernia Surgery: Recovery
As with many surgeries, hiatal hernia surgery recovery requires rest and some temporary lifestyle changes in order for you to heal properly.
Bariatric surgery for weight loss shows greater long-term benefits than GLP-1 medicines
A large Cleveland Clinic study has found that people with obesity and type 2 diabetes who undergo weight-loss surgery live longer and face fewer serious health problems compared with those treated with GLP-1 receptor agonist medicines alone.
Weight loss treatments for people with diabetes and obesity could lower the risk of obesity-related cancers
Weight loss treatments, including medication and surgical procedures, may help lower the risk of obesity-related cancers in people with obesity and type 2 diabetes, a new study shows.
